Journal of Applied Physiology, Vol 71, Issue 6 2412-2418, Copyright © 1991 by American Physiological Society

ARTICLES

Detection of interleukin 1 alpha and 1 beta in rabbit tissues during endotoxemia using sensitive radioimmunoassays

B. D. Clark, I. Bedrosian, R. Schindler, F. Cominelli, J. G. Cannon, A. R. Shaw and C. A. Dinarello
Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts.

Interleukin 1 (IL-1) is a primary mediator of a wide variety of immunologic and inflammatory responses, including reactions to microbial infections. To study this cytokine in an animal model, we have developed specific and sensitive radioimmunoassays for the quantitation of rabbit IL-1 alpha and IL-1 beta. The sensitivity (limit of detection at 95% confidence level) of our assay for IL-1 alpha and 1 beta was 20-40 and 40-80 pg/ml, respectively. Recovery of IL-1 from tissues ranged from 75 to 107%, with a mean of 95% for IL-1 alpha and 89% (range 19-98) for IL-1 beta. We employed these assays in in vivo and in vitro studies. In an in vivo model, we measured the amount of rabbit IL-1 alpha and 1 beta protein present in brain, kidney, liver, lung, muscle, and spleen at various times after the injection of endotoxin. IL-1 was found in all tissues studied but largely in the spleen; IL-1 levels were transient, reaching peak levels by 4 h after injection of endotoxin and rapidly decreasing to low levels by 24 h. In similar in vitro studies, IL-1 alpha levels reached peak elevation 6 h after addition of endotoxin, whereas IL-1 beta was maximal at 24 h. IL-1 alpha was detected in all tissues; IL-1 beta was observed primarily in lung, kidney, and spleen. These studies establish the presence of IL-1 in various tissues during endotoxemia.

This article has been cited by other articles:

				C. Wenneras, P. Ave, M. Huerre, J. Arondel, R. Ulevitch, J. Mathison, and P. Sansonetti Blockade of CD14 aggravates experimental shigellosis Innate Immunity, December 1, 2001; 7(6): 442 - 446. [Abstract] [PDF]

				M. L. Bernardini, J. Arondel, I. Martini, A. Aidara, and P. J. Sansonetti Parameters Underlying Successful Protection with Live Attenuated Mutants in Experimental Shigellosis Infect. Immun., February 1, 2001; 69(2): 1072 - 1083. [Abstract] [Full Text] [PDF]

				N. Harada, K. Okajima, K. Murakami, S. Usune, C. Sato, K. Ohshima, and T. Katsuragi Adenosine and Selective A2A Receptor Agonists Reduce Ischemia/Reperfusion Injury of Rat Liver Mainly by Inhibiting Leukocyte Activation J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 1034 - 1042. [Abstract] [Full Text]

				C. Wenneras, P. Ave, M. Huerre, J. Arondel, R. J. Ulevitch, J. C. Mathison, and P. Sansonetti Blockade of CD14 Increases Shigella-Mediated Invasion and Tissue Destruction J. Immunol., March 15, 2000; 164(6): 3214 - 3221. [Abstract] [Full Text] [PDF]

				R. S. Hotchkiss, P. E. Swanson, C. M. Knudson, K. C. Chang, J. P. Cobb, D. F. Osborne, K. M. Zollner, T. G. Buchman, S. J. Korsmeyer, and I. E. Karl Overexpression of Bcl-2 in Transgenic Mice Decreases Apoptosis and Improves Survival in Sepsis J. Immunol., April 1, 1999; 162(7): 4148 - 4156. [Abstract] [Full Text] [PDF]

				N. Harada, K. Okajima, S. Kushimoto, H. Isobe, and K. Tanaka Antithrombin Reduces Ischemia/Reperfusion Injury of Rat Liver by Increasing the Hepatic Level of Prostacyclin Blood, January 1, 1999; 93(1): 157 - 164. [Abstract] [Full Text] [PDF]

				D.-M. CHANG, K. HSU, Y.-A. DING, and C.-H. CHIANG Interleukin-1 in Ischemia-Reperfusion Acute Lung Injury Am. J. Respir. Crit. Care Med., October 1, 1997; 156(4): 1230 - 1234. [Abstract] [Full Text] [PDF]